We are a large multi-disciplinary department, which aims to tackle some of the world’s biggest health challenges by integrating innovative basic biology with cutting edge clinical research. We have internationally renowned programmes in a range of areas including cardiovascular sciences, diabetes and endocrinology, immunology, haematology and pathology.
Phenotypic and molecular characterization of a serum-free miniature erythroid differentiation system suitable for high-throughput screening and single-cell assays.
Mettananda S. et al, (2018), Exp Hematol, 60, 10 - 20
Genome and epigenome engineering CRISPR toolkit for in vivo modulation of cis-regulatory interactions and gene expression in the chicken embryo.
Williams RM. et al, (2018), Development, 145
MAIT cell clonal expansion and TCR repertoire shaping in human volunteers challenged with Salmonella Paratyphi A.
Howson LJ. et al, (2018), Nat Commun, 9
In situ functional dissection of RNA cis-regulatory elements by multiplex CRISPR-Cas9 genome engineering.
Wu Q. et al, (2017), Nat Commun, 8
Karamitros D. et al, (2018), Nat Immunol, 19, 85 - 97
2018 RDM Experience Surveys
RDM has released two experience surveys for 2018. The surveys cover all staff – academic, research and professional and support staff and students. We value your input and would be very grateful if you could take the time to let us know your thoughts. The surveys take an average of about 20 minutes to complete and can be accessed here. It will close at midnight on Tuesday 31st July 2018. This is an opportunity to tell us what we are doing well and what we need to improve.